Acessibilidade / Reportar erro

Causes of death and mortality trends related to hemophilia in Brazil, 1999 to 2016

ABSTRACT

Introduction

Multiple cause of death methodology enhances mortality studies beyond the traditional underlying cause of death approach.

Aim:

This study aims to describe causes of death and mortality issues related to haemophilia with the use of multiple-cause-of-death methodology.

Methods:

Annual male haemophilia mortality data was extracted from the public multiple-cause-of-death databases of the Mortality Information System, searching deaths included in rubrics D66 "hereditary factor VIII deficiency" (haemophilia A), and D67 "hereditary factor IX deficiency" (Haemophilia B) of the International Classification of Diseases, Tenth Revision, and processed by the Multiple Cause Tabulator.

Results:

In Brazil, from 1999 to 2016, a total of 927 male deaths related to haemophilia occurred during the 18 year period, of which 418 (45,1 %) as underlying cause, and 509 (54,9 %) as associated cause of death. The leading associated cause of 418 deaths of haemophilia as underlying cause was hemorrhage (52.6%), half of which intracranial hemorrhage. Infectious and parasitic diseases accounted for 40,5% as the underlying causes of 509 deaths where haemophilia was an associated cause, where human immunodeficiency virus disease prevailed, however falling from 37,0% to 19.7%, and viral hepatitis increased from 6.0% to 7.9%; diseases of the circulatory system, increased from 13.5% to 18.4%, including intracranial hemorrhage from 5.7% to 7.0%, and neoplasms, from 8,5% to 13.2%, respectively from 1999-2007 to 2008-2016, followed as main underlying causes.

Conclusion:

Hemorrhages, mainly intracranial hemorrhage, human immunodeficiency virus disease, and viral hepatitis are the chief prevention goals aiming at the control of haemophilia mortality.

Keywords
Haemophilia; Mortality trends; Cause of death; Hemorrhage; Intracranial hemorrhage

Introduction

The hemophilias are rare inherited bleeding disorders caused by a low concentration of coagulation factors VIII (hemophilia A) and IX (hemophilia B), both showing recessive X-linked inheritance. Due to the hereditary pattern, hemophilia patients are almost invariably male, whereas women can be carriers of the condition. 11 Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003;361:1801-9. According to the World Federation of Hemophilia, Brazil has the fourth largest population of patients, totaling 12,432 persons, after India, the United States and China. 22 World Federation of Haemophilia. Annual global survey 2017. Quebec, Canada: Montreal; 2018. The prevalence for hemophilia A and B in Brazil in 2016 were 1/10,000 and 0.7/35,000 males, respectively. 33 Ministério da Saúde. Perfil das coagulopatias hereditárias: 2016. Brasília, Brasil: Ministério da Saúde; 2018, 57 pp. From 2000 to 2014, the overall mortality related to hemophilia was 13% higher than that which was observed in the Brazilian male population. 44 Jardim LL, van der Borm JG, Caram-Deelder C, Gouw AC, Cherchiglia ML, Rezende SM. Mortality of patients with haemophilia in Brazil: first report. Haemophilia. 2019;:1-7.

The use of multiple-cause-of death methodology is considered necessary to provide additional useful information to the conventional underlying cause of death presented in primary mortality statistics. 55 Santo AH. Potencial epidemiológico da utilização das causas múltiplas de morte por meio de suas menções nas declarações de óbito, Brasil, 2003. Rev Panam Salud Publica. 2007;22(3):178-86.,66 Aouba A, Rey G, Pavillon G, Jougla E, Rothschild C, Torchet MF, et al. Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies. Haemophilia. 2012;18:339-44. All causes of death listed in the International Form of Medical Certificate of Cause of Death are considered. Multiple-cause-of-death statistics have been available in Brazil since 1999 and in the State of São Paulo, since 1983. 55 Santo AH. Potencial epidemiológico da utilização das causas múltiplas de morte por meio de suas menções nas declarações de óbito, Brasil, 2003. Rev Panam Salud Publica. 2007;22(3):178-86. This study aims to describe causes of death and mortality issues related to hemophilia, using multiple-cause-of-death methodology.

Material and methods

Brazil, officially named Federative Republic of Brazil, is the world's fifth largest country, covering a total territory of 8.5 million km2, and it has the sixth largest population, estimated at 210 million inhabitants in 2019. The country is politically and administratively divided into 27 federated units (26 states and the Federal District) and 5570 municipalities. The 27 federated units are grouped into five geographic regions: North, Northeast, Southeast, South and Center-West.

The annual male hemophilia mortality data were extracted from the public multiple-cause-of-death databases of the Mortality Information System (Sistema de Informações sobre Mortalidade (SIM)), located in the Brazilian Unified Health System Information Technology Department (Departamento de Informática do Sistema Único de Saúde (DATASUS)), Ministry of Health. 77 Ministério da Saúde. Departamento de Informática do SUS. Acesso à Informação. Serviços. transferência-download-de-arquivos.arquivos-de-dados. Available from: http://www2.datasus.gov.br/DATASUS/index.php?area=0901&item=1&acao=26&pad=31655.
http://www2.datasus.gov.br/DATASUS/index...
All deaths were selected in which hemophilia, as a cause of death, was listed on any line, or in either part of the International Form of Medical Certificate of Cause of Death (the medical certification section of the death certificate), irrespective of whether characterized as the underlying cause of death or as an associated (non-underlying) cause. Complications of the underlying cause (Part I of the medical certification section) and contributing causes (Part II of the medical certification section) were jointly designated as associated (non-underlying) causes of death. 88 World Health Organization. International classification of diseases and related health problems. Geneva: World Health Organization; 1993. Tenth Revision. Volume 2 Instruction Manual.

Male deaths included under the rubrics D66 "hereditary factor VIII deficiency" (Hemophilia A) and D67 "hereditary factor IX deficiency" (Hemophilia B) of the International Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10), 99 World Health Organization. International classification of diseases and related health problems. Geneva: World Health Organization; 1992, 1, Tenth Revision. were studied. To reconstruct the morbid process leading to death, all causes of death listed in the medical certification section of the death certificate were considered, including those classified as ill-defined, equated as such, or considered by the World Health Organization (WHO) as modes of death. 88 World Health Organization. International classification of diseases and related health problems. Geneva: World Health Organization; 1993. Tenth Revision. Volume 2 Instruction Manual.,99 World Health Organization. International classification of diseases and related health problems. Geneva: World Health Organization; 1992, 1, Tenth Revision.

The causes of death were automatically processed with the software Underlying Cause Selector (Seletor de Causa Básica (SCB)). 1010 Santo AH. Uso do microcomputador na seleção da causa básica de morte [Use of a microcomputer in the selection of underlying cause of death]. Bol Oficina Sanit Panam. 1995;119:319-27. The automatic processing involves the use of algorithms and decision tables that incorporate the WHO mortality standards and the etiological relationships among the causes of death. The expressions "death from" and "death due to" refer to the underlying cause of death, whereas "deaths with a mention of" and "mortality related to" refer to the listing of a given condition, either as the underlying cause or as an associated cause. The causes of death evaluated in the present study were those mentioned in the medical certification section, which are known internationally as "entity axis codes", defined and presented under the structure and headings of the ICD.

Records included in the mortality databases contain fields similar to those appearing on official Brazilian death certificates. In addition, auxiliary fields were created for the study of multiple causes, including a field designed to contain a single "string" of characters composed of the codes entered in lines (a), (b), (c) and (d) of Parts I and II of the medical certification section of the death certificate.

Using proportions and historical trends, the distributions of the following variables were considered: age at death, year of death, underlying cause of death, associated (non-underlying) cause(s) of death, total mentions of each cause of death, mean number of causes listed per death certificate and geographical distribution of deaths. The evaluation of cause-of-death changes in time trends was performed in two periods: 1999 to 2007 and 2008 to 20,016. Medical and demographic variables were processed with the following software: dBASE III Plus, version 1.1, dBASE IV (Ashton-Tate Corporation, Torrance, CA), Epi Info, version 6.04d (Centers for Disease Control and Prevention, Atlanta, GA) and in the emulated dbDOS™ PRO 6 environment, Excel 2016 (Microsoft Corporation, Redmond, WA). The Multiple Causes Tabulator (Tabulador de Causas Múltiplas) (TCMWIN, version 1.6) program for Windows (DATASUS, Ministério da Saúde, Faculdade de Saúde Pública, Universidade de São Paulo, Brazil) was used to process ICD-10 codes in the presentation of associated causes and mean number of causes per death certificate. 1111 Santo AH. Tabulador de causas múltiplas de morte [Multiple causes-of-death tabulador]. Rev Brasil Epidemiol. 1999;2:90-7.

The associated causes of death were generated by special lists showing the conditions involved in the natural histories of their underlying causes, also considering lists reported by Jardim et al. and Chorba et al., 33 Ministério da Saúde. Perfil das coagulopatias hereditárias: 2016. Brasília, Brasil: Ministério da Saúde; 2018, 57 pp.,1212 Chorba TL, Holman RC, Strine TW, Clarke MJ, Evatt BL. Changes in longevity and causes of death among persons with haemophilia A. Am J Hematol. 1994;45:112-21.,1313 Chorba TL, Holman RC, Clarke MJ. Effects of HIV infection on age and cause of death for persons with haemophilia A in the United States. Am J Hematol. 2001;66:229-40. as well as associated causes mentioned most frequently. Due to the importance of intracerebral hemorrhage as a cause of death, it was separated from the causes comprising the overall hemorrhage. The duplication or multiplication of causes of death was avoided when these were presented in abbreviated lists. The number of causes depends on the breadth of the class (subcategory, category, grouping or chapter of the ICD-10); therefore, if two or more causes mentioned in the medical certification section were included in the same class, only one cause was computed. 1111 Santo AH. Tabulador de causas múltiplas de morte [Multiple causes-of-death tabulador]. Rev Brasil Epidemiol. 1999;2:90-7. Analysis of variance compared the mean numbers of causes mentioned on the death certificate and the Kruskal-Wallis H test compared the mean age at death between the studied groups.

Results

In Brazil, from 1999 to 2016, a total of 927 overall male deaths related to hemophilia occurred during the 18-year period, an average of 52 per year, ranging from 41 in 2009 to 68 in 2003, of which in 418 (45.09%) it was the underlying cause and in 509 (54.91%), the associated (non-underlying) cause of death. The identification of hemophilia as the underlying cause of death varied from 35.71% in 2010 to 68.29% in 2009 and in the Brazilian regions, 66.18% in the North, 51.67% in the Northeast, 35.93% in the Southeast, 50.63% in the South and 47.83% in the Center-West. Hemophilia A and B were identified as the underlying cause in 393 deaths on 25 death certificates and as the associated cause in 475 deaths on 34 death certificates, respectively.

Hemophilia deaths were noticed in all age groups, nonetheless 50% of underlying and associated (non-underlying) deaths occurred before 35 and 41 years of age, respectively. For all mentions, overall mean ages at death for the entire period were 38.949 (±21.882), however higher mean ages were verified for the associated cause and second period deaths, compared to the underlying cause and first period deaths. Lower mean ages were also noticed in the North and Northeast regions. (Table 1) For the underlying cause deaths, the modal age at death was 1.5 years, with 12 deaths.

Table 1
Ages at death related to hemophilia, mean, standard deviation and median, according to causes of death, periods and regions in Brazil, 1999-2016.

The leading associated (non-underlying) causes of 418 deaths in which hemophilia was identified as the underlying cause for the periods 1999-2007 and 2008-2016 are displayed in descending order in Table 2. For the entire period, hemorrhage (26.3%) and intracerebral hemorrhage (26.3%) must be emphasized, totalizing 52.6% for overall hemorrhages. Subsequently, shock (21.3%), respiratory failure (11.7%), septicemias (9.1%), cardiac arrest (8.1%) and organ failures appear as direct causes of death. Also noteworthy is intracranial hypertension, coded as G93.2, occurring in 6.9% of these deaths, the majority of which (22/29, or 75.9%) were intracranial hemorrhages. An increase in viral hepatitis and a decrease in HIV disease occurred between periods. Among the 110 deaths with intracranial hemorrhage as the associated cause, the mean overall age at death was 32.901 (±23.978) years and during the first and second studied periods, 28.492 (±23.803) and 37.811 (±23.423) years, respectively; at 20 years of age or less, 45 (40.9%) deaths occurred. The crude mean numbers of 3.20 (±1.66), 3.11(±1.48) and 3.31 (±1.84) causes per death certificate were mentioned overall and during the first and second periods, respectively.

Table 2
Associated (non-underlying) causes of death on death certificates where hemophilia was identified as the underlying cause, Brazil, 1999-2016.

Table 3 presents the underlying causes of 509 deaths in which hemophilia was identified as an associated (non-underlying) cause of death. The ICD-10 Chapter I: Certain infectious and parasitic diseases covers 40.5% of all the underlying causes in the whole period, in which HIV disease prevailed, however dropping from 37.0% to 19.7%, and viral hepatitis presenting a small increase, from 6.0% to 7.9%, from 1999-2007 to 2008-2016, respectively. Among the 149 deaths with HIV disease as the underlying cause, the mean overall ages at death and during the first and second periods were 36.795 (±11.167), 33.712 (±10.053) and 43.922 (±10.413), respectively. Diseases of the circulatory system, increasing from 13.5% to 18.4%, including intracranial hemorrhage, from 5.7% to 7.0%, and neoplasms, from 8.5% to 13.2%, between the periods, followed as the main underlying causes. Among the external causes of death, eight traffic accidents and nine falls occurred. Six deaths due to intracranial hemorrhage in newborn children are shown in detail.

Table 3
Underlying causes of death on death certificates that listed hemophilia as associated (non-underlying) cause of death, Brazil, 1999-2016.

The associated (non-underlying) causes of these 509 deaths are presented in Table 4. Septicemias (25.9%), respiratory failure (18.1%), viral hepatitis (16.9%), liver diseases (15.7%), hemorrhage (12.6%), multiple-organ failures (11.8%) and pneumonias (11.4%) were the related associated conditions of the above-mentioned underlying causes, as well as hemophilia. These death certificates included the crude mean numbers of 4.42 (±1.51), 4.44 (±1.49) and 4.41 (±1.55) causes mentioned overall and during the first and second studied periods.

Table 4
Associated (non-underlying) causes of death on death certificates in which hemophilia was also an associated cause, Brazil, 1999-2016.

Bearing in mind all mentions of a given cause of death, a compact synthesis of its effect on mortality can be reached by adding the number of deaths described in Tables 2-44 Jardim LL, van der Borm JG, Caram-Deelder C, Gouw AC, Cherchiglia ML, Rezende SM. Mortality of patients with haemophilia in Brazil: first report. Haemophilia. 2019;:1-7., both as underlying and associated causes. There were 350 deaths due to hemorrhage: 174 intracranial hemorrhages and 176 other hemorrhages, corresponding to 37.8% among 927 total deaths. All mentions of HIV disease were 186, viral hepatitis, 149, liver diseases, 119, septicemias, 178 and hypertensive disease, 59. 16,210:36.

Discussion

The mortality related to hemophilia was studied using the methodology of multiple causes of death. Hence, it was possible to take advantage of all resources included in the structure of the WHO International Form of Medical Certificate of Cause of Death, correlated guidance and dispositions of mortality coding instructions. 88 World Health Organization. International classification of diseases and related health problems. Geneva: World Health Organization; 1993. Tenth Revision. Volume 2 Instruction Manual. All deaths required a specific underlying cause, their causal consequences and contributory conditions, these latter ones herein designated as associated (non-underlying) causes. The leading causes of death in hemophilia have been commonly studied altogether, without a specification of their characteristics and labels on the death certificate. As expected, hemorrhages and HIV disease, for instance, were the main definite causes of death, whose proportional values may differ from the ones verified in the present study, in which these conditions are evaluated in association with hemophilia or specified causes of death.

Around 45% of the deaths were identified as having an underlying cause, a fact which shows the opinion of certifiers about the qualification of hemophilia, suggestive of a certain degree of its severity. Although such data is not available on death certificates, most of them were completed by the attending physician, who had knowledge of the lethal process. In addition, the crude mean numbers of the above three causes per certificate provide a reasonable description of these deaths. The severity of these deaths was also confirmed by their earlier mean ages, compared to the corresponding ages of non-underlying deaths for the entirety and during both periods, as well as in all Brazilian regions. Early age at death has been considered one indicator of hemophilia severity. 11 Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003;361:1801-9.,1313 Chorba TL, Holman RC, Clarke MJ. Effects of HIV infection on age and cause of death for persons with haemophilia A in the United States. Am J Hematol. 2001;66:229-40. The hallmark of severe hemophilia is spontaneous bleeding in joints and muscles; most children with severe hemophilia experience their first bleed in a joint by age 4 years, but many bleeds at other sites occur before this age. 11 Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003;361:1801-9. Similar studies that consider the extent of congenital hemophilia qualified as the underlying cause of death were not found. However, Aouba et al. observed that among 121 deaths in France acquired hemophilia was identified as the underlying cause of death in 69.4% of the time between 2000 and 2009 and was more frequent in older subjects. 66 Aouba A, Rey G, Pavillon G, Jougla E, Rothschild C, Torchet MF, et al. Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies. Haemophilia. 2012;18:339-44. The variation from 35% to 68% percent as the underlying cause verified between the years of death and Brazilian regions might be due in part to small numbers. Certainly, specific regional studies would contemplate certification and causal differences, aiming to explain these data.

Previous studies have described the age at death for hemophilia according to the severity, causes of death and time periods. In Greece, between 1972 and 1993, Koumvorelis et al. found the mean age at death of 44 among hemophiliacs, while in severe ones, it was 39 and in mild hemophilia, 53. 1414 Koumbarelis E, Rosendaal FR, Gialeraki A, Karafoulidou A, Noteboom WM, Loizou C, et al. Epidemiology of haemophlia in Greece: an overview. Thromb Haemost. 1994;72(6):808-13. Lövdahl et al. reported for all deaths in Sweden during the periods 1981-1990, 1991-2000 and 2001-2008 the mean ages of death of 58.5, 59.9 and 69.4 years, respectively, and for the subgroup of severe hemophilia, the mean ages of 45.6, 40.5 and 56.0 years, respectively. 1515 Lövdahl S, Henriksson KM, Baghaei F, Holmström M, Nilsson JÅ, Berntorp E, et al. Incidence, mortality rates and causes of death in haemophilia patients in Sweden. Haemophilia. 2013;19:362-9. Chang et al. reported the mean age at death of 44.44 years for overall hemophiliacs in Taiwan between 1977 and 2009 and 40.83 and 49.98 years for the periods 1997-2004 and 2005-2009, respectively. 1616 Chang CY, Yeh GC, Lin SY, Tseng IJ, Tsai CH, Lee YW. Trends in the epidemiology, diagnosed age and mortality rate of haemophilics in Taiwan: a population-based study, 1997-2009. Haemophilia. 2014;20:535-40. Neme et al. verified that from 2008 through 2012 in Argentina the mean age at death of severe and mild hemophilia patients was 48.5 and 66 years old, respectively. 1717 Neme D, Simon H, Candela M, Rode B, Elhelou L, Pinto MT. Causes of death in hemophilia patients in Argentina. Haemophilia. 2014;20(Suppl. 3):33. Payne et al. in the Unites States observed the increase in the mean age of death of hemophiliacs in the period 1999-2011 from 51 to 62 years and the increase in the median age in the period 1999-2014 from 49 to 63 years. 1818 Payne AB, Ghaji N, Mehal JM, Holman RC, Soucie JM, Hooper WC. Mortality trends and causes of death n persons with hemophilia, United States, 1999-2010. Am J Hematol. 2016;91(9):E413-4.,1919 Payne AB, Ghaji N, Mehal JM, Kempton CL, Haberling DL, Chapman C, et al. Mortality trends and causes of death in persons with hemophilia in the United States, 1999-2014. Blood. 2017;130(Suppl. 1):755. In Brazil, where the life expectancy for males was 73 years in 2019, the overall mean age at death of male hemophiliacs for the entire period of 1999 to 2016 was 38.9 years, somewhat lower than that observed in other countries. This result was strongly influenced by the mean ages of 26.3 and 32.7 years observed in the less developed North and Northeast regions of the country. Otherwise, an increase of 25.3% was verified for overall mean ages between the periods 1999-2007 and 2008-2016, a fact that reflects the efforts of the Ministry of Health to implement hemophilia care in the country, increasing the purchase of factor concentrates, implementing short home treatments, prophylaxis programs, immune tolerance inductions and initiating a web-based registry of patients with inherited bleeding disorders. 44 Jardim LL, van der Borm JG, Caram-Deelder C, Gouw AC, Cherchiglia ML, Rezende SM. Mortality of patients with haemophilia in Brazil: first report. Haemophilia. 2019;:1-7.,2020 Rezende SM, Rodrigues SH, Brito KNP, Quintino da Silva DL, Lázaro Santo M, de Jesus Simões B, et al. Evaluation of a web-based registry of inherited bleeding disorders: a descriptive study of the Brazilian experience with HEMOVIDAweb Coagulopatias. Orphanet J Rare Dis. 2017;12:27.

In deaths in which hemophilia was identified as the underlying cause, hemorrhages occurred in 52.6% as the leading associated cause. Half of these causes, considered wide-ranging hemorrhage, include bleeding causes scattered in diverse organs and sites, whereas the remaining causes comprise the well-specified intracranial hemorrhage, which is the most serious event that can occur in hemophiliacs, resulting in fatality rates of around 20% and disability. 2121 Zanon E, Pasca S. Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years. Blood Transfus. 2019;17:378-84. It is thought that intracranial hemorrhage occurs more frequently in childhood, mostly in children ages under 2 years, and in adulthood due to the risks of hypertension and age over 60 years. 2121 Zanon E, Pasca S. Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years. Blood Transfus. 2019;17:378-84. In Brazil, premature deaths related to intracranial hemorrhage, as associated causes of hemophilia, present a mean age of death lower than the overall corresponding underlying cause deaths and approximately 40% occur before 20 years of age (15 children <2 years). In contrast, nine deaths occurred where hypertension was also associated and the mean age at death was 51.944 (±8.156), with ages ranging from 38 to 64 years. The severity of hemophilia is consistently considered one of the most significant risk factors for intracranial hemorrhage in children and adults. 2121 Zanon E, Pasca S. Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years. Blood Transfus. 2019;17:378-84. The suggestive severity of hemophilia implied in these deaths was discussed, nevertheless observing the absence of such information on death certificates; in Brazil, a linkage between the mortality and the inherited bleeding disorders registry systems would overcome the problem. 77 Ministério da Saúde. Departamento de Informática do SUS. Acesso à Informação. Serviços. transferência-download-de-arquivos.arquivos-de-dados. Available from: http://www2.datasus.gov.br/DATASUS/index.php?area=0901&item=1&acao=26&pad=31655.
http://www2.datasus.gov.br/DATASUS/index...
,2020 Rezende SM, Rodrigues SH, Brito KNP, Quintino da Silva DL, Lázaro Santo M, de Jesus Simões B, et al. Evaluation of a web-based registry of inherited bleeding disorders: a descriptive study of the Brazilian experience with HEMOVIDAweb Coagulopatias. Orphanet J Rare Dis. 2017;12:27.

Since the early 1980s, acquired immunodeficiency syndrome (AIDS) and liver diseases have arisen as the leading causes of death in the form of human immunodeficiency virus [HIV] and hepatitis C virus, both transmitted by plasma-derived clotting factor concentrates. 1212 Chorba TL, Holman RC, Strine TW, Clarke MJ, Evatt BL. Changes in longevity and causes of death among persons with haemophilia A. Am J Hematol. 1994;45:112-21.,1313 Chorba TL, Holman RC, Clarke MJ. Effects of HIV infection on age and cause of death for persons with haemophilia A in the United States. Am J Hematol. 2001;66:229-40.,2222 Walker IR, Julian JA. Causes of death in Canadians with haemophilia 1980-1995. Haemophilia. 1998;4:714-20.,2323 Arnold DM, Julian JA, Walker IR. Mortality rates and causes of death among all HIV-positive individuals with haemophilia in Canada over 21 years of follow-up. Blood. 2006;108(2):460-4. In the mid-1980s, virally inactivated factor concentrates were introduced and transfusion-transmitted infections ceased, however their chronic nature continues to influence mortality. 2121 Zanon E, Pasca S. Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years. Blood Transfus. 2019;17:378-84.,2222 Walker IR, Julian JA. Causes of death in Canadians with haemophilia 1980-1995. Haemophilia. 1998;4:714-20. The contemporary impact, predominantly of AIDS and viral hepatitis as the underlying causes of death in Brazil, was considered through the amount of their associated causes. Accordingly, with 149 deaths from AIDS, the main associated causes and corresponding numbers were septicemias (55), viral hepatitis (48), respiratory failure (38), liver diseases (34), pneumonias (29), other respiratory diseases (20), other infectious diseases (18), toxoplasmosis (16), tuberculosis (12), hemorrhages (10) and renal failure (10). Similarly, in 35 deaths with viral hepatitis as the underlying cause, the main associated causes were liver diseases (27), hemorrhage (12), septicemias (10) and shock (8).

From 2000 to 2014, Jardim et al. found in Brazil 32.4% of hemorrhage as the most frequently reported among all mentions of causes of death, 44 Jardim LL, van der Borm JG, Caram-Deelder C, Gouw AC, Cherchiglia ML, Rezende SM. Mortality of patients with haemophilia in Brazil: first report. Haemophilia. 2019;:1-7. while in this study, the rate found was 37.8% from 1999 to 2106. This slight increase may be explained by the improvement in mortality statistics in the country during recent years, mainly for multiple-cause-of-death statistics. 2424 Santo AH, Pinheiro CE. Reavaliação do potencial epidemiológico das causas múltiplas de morte no Brasil; 2015 [Reevaluation of the epidemiological multiple-cause-of-deathpotential use in Brazil, 2015] Research Gate, preprint.,2525 Santo AH, Pinheiro CE. Reassessment of the epidemiological multiple-cause-of-death potential use in Brazil. In: Presented at the fourth international meeting on multiple cause-of-death analysis. 2015. Incidentally, mortality statistics also comprise one of the main limitations of the study. Population mortality statistics suffer from quantity and quality problems. All death certificates are completed by physicians, but incorrect completion may occur. The crude mean number of causes mentioned on death certificates ranks among the highest in the world. However, hemophilia is a rare cause of death and difficulties may arise during coding and automatic processing of data, mainly with neonatal deaths.

In conclusion, the study revealed that the mean age of deaths related to hemophilia in Brazil is lower than that of other countries, mainly when identified as the underlying cause of death. The leading associated cause of hemophilia as the underlying cause of death was hemorrhage, half of which intracranial hemorrhage. When hemophilia was an associated cause, infectious and parasitic diseases were the main underlying causes of deaths, human immunodeficiency virus prevailing, however declining, while viral hepatitis increased, as well as diseases of the circulatory system and neoplasms. The multiple-cause-of-death methodology enables comprehensive mortality analysis and enhances prevention management measures for specific risk factors.

References

  • 1
    Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003;361:1801-9.
  • 2
    World Federation of Haemophilia. Annual global survey 2017. Quebec, Canada: Montreal; 2018.
  • 3
    Ministério da Saúde. Perfil das coagulopatias hereditárias: 2016. Brasília, Brasil: Ministério da Saúde; 2018, 57 pp.
  • 4
    Jardim LL, van der Borm JG, Caram-Deelder C, Gouw AC, Cherchiglia ML, Rezende SM. Mortality of patients with haemophilia in Brazil: first report. Haemophilia. 2019;:1-7.
  • 5
    Santo AH. Potencial epidemiológico da utilização das causas múltiplas de morte por meio de suas menções nas declarações de óbito, Brasil, 2003. Rev Panam Salud Publica. 2007;22(3):178-86.
  • 6
    Aouba A, Rey G, Pavillon G, Jougla E, Rothschild C, Torchet MF, et al. Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies. Haemophilia. 2012;18:339-44.
  • 7
    Ministério da Saúde. Departamento de Informática do SUS. Acesso à Informação. Serviços. transferência-download-de-arquivos.arquivos-de-dados. Available from: http://www2.datasus.gov.br/DATASUS/index.php?area=0901&item=1&acao=26&pad=31655
    » http://www2.datasus.gov.br/DATASUS/index.php?area=0901&item=1&acao=26&pad=31655
  • 8
    World Health Organization. International classification of diseases and related health problems. Geneva: World Health Organization; 1993. Tenth Revision. Volume 2 Instruction Manual.
  • 9
    World Health Organization. International classification of diseases and related health problems. Geneva: World Health Organization; 1992, 1, Tenth Revision.
  • 10
    Santo AH. Uso do microcomputador na seleção da causa básica de morte [Use of a microcomputer in the selection of underlying cause of death]. Bol Oficina Sanit Panam. 1995;119:319-27.
  • 11
    Santo AH. Tabulador de causas múltiplas de morte [Multiple causes-of-death tabulador]. Rev Brasil Epidemiol. 1999;2:90-7.
  • 12
    Chorba TL, Holman RC, Strine TW, Clarke MJ, Evatt BL. Changes in longevity and causes of death among persons with haemophilia A. Am J Hematol. 1994;45:112-21.
  • 13
    Chorba TL, Holman RC, Clarke MJ. Effects of HIV infection on age and cause of death for persons with haemophilia A in the United States. Am J Hematol. 2001;66:229-40.
  • 14
    Koumbarelis E, Rosendaal FR, Gialeraki A, Karafoulidou A, Noteboom WM, Loizou C, et al. Epidemiology of haemophlia in Greece: an overview. Thromb Haemost. 1994;72(6):808-13.
  • 15
    Lövdahl S, Henriksson KM, Baghaei F, Holmström M, Nilsson JÅ, Berntorp E, et al. Incidence, mortality rates and causes of death in haemophilia patients in Sweden. Haemophilia. 2013;19:362-9.
  • 16
    Chang CY, Yeh GC, Lin SY, Tseng IJ, Tsai CH, Lee YW. Trends in the epidemiology, diagnosed age and mortality rate of haemophilics in Taiwan: a population-based study, 1997-2009. Haemophilia. 2014;20:535-40.
  • 17
    Neme D, Simon H, Candela M, Rode B, Elhelou L, Pinto MT. Causes of death in hemophilia patients in Argentina. Haemophilia. 2014;20(Suppl. 3):33.
  • 18
    Payne AB, Ghaji N, Mehal JM, Holman RC, Soucie JM, Hooper WC. Mortality trends and causes of death n persons with hemophilia, United States, 1999-2010. Am J Hematol. 2016;91(9):E413-4.
  • 19
    Payne AB, Ghaji N, Mehal JM, Kempton CL, Haberling DL, Chapman C, et al. Mortality trends and causes of death in persons with hemophilia in the United States, 1999-2014. Blood. 2017;130(Suppl. 1):755.
  • 20
    Rezende SM, Rodrigues SH, Brito KNP, Quintino da Silva DL, Lázaro Santo M, de Jesus Simões B, et al. Evaluation of a web-based registry of inherited bleeding disorders: a descriptive study of the Brazilian experience with HEMOVIDAweb Coagulopatias. Orphanet J Rare Dis. 2017;12:27.
  • 21
    Zanon E, Pasca S. Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years. Blood Transfus. 2019;17:378-84.
  • 22
    Walker IR, Julian JA. Causes of death in Canadians with haemophilia 1980-1995. Haemophilia. 1998;4:714-20.
  • 23
    Arnold DM, Julian JA, Walker IR. Mortality rates and causes of death among all HIV-positive individuals with haemophilia in Canada over 21 years of follow-up. Blood. 2006;108(2):460-4.
  • 24
    Santo AH, Pinheiro CE. Reavaliação do potencial epidemiológico das causas múltiplas de morte no Brasil; 2015 [Reevaluation of the epidemiological multiple-cause-of-deathpotential use in Brazil, 2015] Research Gate, preprint.
  • 25
    Santo AH, Pinheiro CE. Reassessment of the epidemiological multiple-cause-of-death potential use in Brazil. In: Presented at the fourth international meeting on multiple cause-of-death analysis. 2015.

Publication Dates

  • Publication in this collection
    07 July 2021
  • Date of issue
    Apr-Jun 2021

History

  • Received
    16 Oct 2019
  • Accepted
    17 Feb 2020
  • Published
    4 June 2020
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH) R. Dr. Diogo de Faria, 775 cj 133, 04037-002, São Paulo / SP - Brasil - São Paulo - SP - Brazil
E-mail: htct@abhh.org.br